3billion was selected as a business operator for the national project
3billion plans to form a consortium with Seoul National University Hospital and Kakao Healthcare to develop an AI integrated software solution for multifaceted analysis of rare…
3billion Company Video: From 3 billion bases to 1 answer
3billion released a company video explaining why rare disease is so difficult to diagnose and how 3billion is solving them. Check out the video and learn…
3billion aims to lead genetic diagnosis in global market
Let’s take a look at the interview article with ‘Korea Biomedical Review’ of 3billion’s CEO Changwon Keum. There are many difficulties in diagnosing rare…
3billion will be at ACMG 2022
Diagnostic performance of automated, streamlined, daily updated exome analysis in patients with neurodevelopmental delay3billion announced that Chief Medical Officer Dr. Gohun Seo will be introducing a…
3billion Announced the Winners of the End the Diagnostic Odyssey Grant
3billion recently announced the first recipients of the End The Diagnostic Odyssey Grant. The grant was offering a total of up to $1,000,000 of…
3billion receives accreditation from the College of American Pathologists
3billion has received CAP accreditation on November 15th. CAP accreditation is an evaluation system by the College of American Pathologists, an organization of clinical pathologists in…
3billion selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul
On December 8th, 3billion was selected as a finalist of the Novartis Korea’s Health X-Challenge Seoul for the ‘Genetic retinal disease’ category. 3billion was highly…
3billion announces pathogenicity predictor '3Cnet'
3billion announces 3Cnet, a pathogenicity prediction tool based on recurrent neural networks.…
Immediate Diagnosis Through Collaboration with Dr. Alisdair McNeill
“I was surprised that such a recent publication would be incorporated into clinical reporting so rapidly. It is good practice that the latest evidence is incorporated.…
3billion announces Dr. Hane Lee of UCLA as Chief Clinical Geneticist
3billion has announced Dr. Hane Lee, a former UCLA professor of pathology/diagnostic medicine and human genetics, as 'Chief Clinical Geneticist and Director of Clinical Genetic…
3billion looks to 2022 IPO, expansion into drug discovery
The Korean startup, having only been founded in October 2016, is already on track to go public in early 2022 on the KOSDAQ. The KOSDAQ and…
Rare disease screening firm 3Billion closes $13M Series C financing
The Korean startup 3billion has officially closed its Series C funding by raising $13 million. They have raised a total of $30 million since its seed…